Pharmaron Beijing Co., Ltd. (3759.HK) HKSE

16.60

-0.56(-3.26%)

Updated at June 03 03:24PM

Currency In HKD

Valuation

Market Cap31B
Enterprise Value33.4B
P/E Ratio25.05
PEG Ratio-2.92
Price/Sales Ratio2.39
Price/Book Ratio2.58
Enterprise/Revenue2.72
Enterprise/EBITDA13.69

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.12
Operating Margin0.14

Management Effectiveness

Return On Assets0.06
Return On Equity0.11

Income Statement

Revenue14.1B
Revenue/Share8.05
Gross Profit4.91B
EBITDA3.29B
Net Income1.66B
Diluted EPS0.94

Balance Sheet

Total Cash2.97B
Total Cash/Share1.65
Total Debt7.08B
Total Debt/Equity0.43
Current Ratio1.08
Book Value Per Share9.49

Price History

52-Week Change13.93
52-Week High30.12
52-Week Low14.98
Moving Average 50 Days19.69
Moving Average 200 Days21.8

Statistics

Average Volume5.82M
Shares Outstanding2.73B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.85
Payout Ratio0.08
Last Split Factor3:2
Last Split DateJuly 18, 2023